A PHASE-III RANDOMIZED COMPARISON OF MDL (METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM) PLUS GRANISETRON WITH MDL ALONE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTI-DAY CISPLATIN-CONTAINING CHEMOTHERAPY
Yk. Kang et al., A PHASE-III RANDOMIZED COMPARISON OF MDL (METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM) PLUS GRANISETRON WITH MDL ALONE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTI-DAY CISPLATIN-CONTAINING CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 1238-1238